Literature DB >> 177804

[Stimulation of growth hormone and prolactin secretion with TRH in acromegaly (author's transl)].

K von Werder, R Fahlbusch, R Gay, C R Pickhardt, B Schultz.   

Abstract

Inappropriate stimulation of growth hormone (hGH)-secretion with TRH in acromegalic subjects has been shown previously, whereas prolactin (hPRL) secretion was reported to be blunted in active acromegaly. In this study TRH induced hGH and hPRL secretion was investigated in 23 active (mean hGH level: 68.5 +/- 19.9 ng/ml; +/- SE) and 15 inactive acromegalics (mean hGH level: 2.3 +/- 0.4 ng/ml; +/- SE). Fourteen of the active acromegalics showed a significant increase up to more than double of the basal hGH level after 200 mug TRH while in only one of the inactive acromegalics an inappropriate rise of hGH was induced by TRH. Basal hPRL levels were elevated in 9 and within normal range in 14 of the patients with active acromegaly. Except in 3 patients who had normal basal hPRL levels and in one patient with excessively elevated hPRL and hGH levels due to an hPRL and hGH producing adenoma, all patients had normal hPRL responses to TRH. In those with inactive acromegaly, 9 had hPRL levels below normal and only , out of the 15 patients showed a normal rise of hPRL after TRH. The patients who showed no hPRL response to TRH demonstrated also other signs of pituitary insufficiency due to the operative procedure. In contrast to a previous report these findings demonstrate that normal or enhanced hPRL secretion is found in active acromegaly. The inappropriate rise of hGH after TRH is compatible with a loss of specificity of the receptor for GRH of the adenoma cell and can be found also in patients with normal basal hGH levels after treatment suggesting that remaining adenoma tissue is present in the pituitary fossa.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 177804     DOI: 10.1007/bf01471580

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  13 in total

1.  Thyrotropin releasing hormone: direct evidence for stimulation of prolactin production by pituitary cells in culture.

Authors:  A H Tashjian; N J Barowsky; D K Jensen
Journal:  Biochem Biophys Res Commun       Date:  1971-05-07       Impact factor: 3.575

2.  Plasma growth hormone response to thyrotropin-releasing hormone in patients with active acromegaly.

Authors:  G Faglia; P Beck-Peccoz; C Ferrari; P Travaglini; B Ambrosi; A Spada
Journal:  J Clin Endocrinol Metab       Date:  1973-06       Impact factor: 5.958

3.  A homologous radioimmunoassay for human prolactin.

Authors:  Y N Sinha; F W Selby; U J Lewis; W P VanderLaan
Journal:  J Clin Endocrinol Metab       Date:  1973-03       Impact factor: 5.958

4.  Growth hormone, thyrotropin, and prolactin responses to thyrotropin-releasing hormone following diethylstilbestrol pretreatment.

Authors:  H E Carlson; L S Jacobs; W H Daughaday
Journal:  J Clin Endocrinol Metab       Date:  1973-09       Impact factor: 5.958

5.  The hormones of the hypothalamus.

Authors:  R Guillemin; R Burgus
Journal:  Sci Am       Date:  1972-11       Impact factor: 2.142

6.  [Stimulation of TSH secfetion by TRF load in hypothalamic and pituitary diseases].

Authors:  C R Pickardt; W Geiger; R Fahlbusch; P C Scriba
Journal:  Klin Wochenschr       Date:  1972-01-01

7.  Suppression by thyrotropin-releasing hormone (TRH) of human growth hormone release induced by L-dopa.

Authors:  K Maeda; Y Kato; K Chihara; S Ogo; Y Iwasaki
Journal:  J Clin Endocrinol Metab       Date:  1975-08       Impact factor: 5.958

8.  Inhibition by somatostatin of basal levels of serum thyrotropin (TSH) in normal men.

Authors:  J Weeke; A P Hansen; K Lundaek
Journal:  J Clin Endocrinol Metab       Date:  1975-07       Impact factor: 5.958

9.  Growth hormone and prolactin release after injection of thyrotropin-releasing hormone in patients with depression.

Authors:  K Maeda; Y Kato; S Ohgo; K Chihara; Y Yoshimoto; N Yamaguchi; S Kuromaru; H Imura
Journal:  J Clin Endocrinol Metab       Date:  1975-03       Impact factor: 5.958

10.  Responses to thyrotropin-releasing hormone in patients with renal failure and after infusion in normal men.

Authors:  D Gonzalez-Barcena; A J Kastin; D S Schalch; M Torres-Zamora; E Perez-Pasten; A Kato; A V Schally
Journal:  J Clin Endocrinol Metab       Date:  1973-01       Impact factor: 5.958

View more
  2 in total

1.  [Comparative studies of growth hormone secretion in acromegaly after isolated and combined application of insulin hypoglycemia, LH-RH- and TRH tests (author's transl)].

Authors:  K R Schneider; G Müller; W Wiegelmann; H G Solbach; H L Krüskemper
Journal:  Klin Wochenschr       Date:  1978-05-01

2.  TRH: pathophysiologic and clinical implications.

Authors:  C R Pickardt; P C Scriba
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.